SutroVax Appoints Alan Kimura Chief Medical Officer

Alan Kimura is joining Foster City, CA, vaccine developer SutroVax as chief medical officer. Kimura’s experience includes senior positions at Translate Bio, Novartis (NYSE: [[ticker:NVS]]) and Shire (NASDAQ: [[ticker:SHPG]]). Earlier this year, SutroVax raised $64 million in financing to start clinical testing of its vaccine candidate for pneumococcal infections.

In other moves, SutroVax named Durga Bobba chief business officer, and Aron Stein was appointed vice president of regulatory affairs and quality assurance.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.